Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2021-04-29 Capital/Financing Update
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정) by Solco Biomedical Co., Ltd. It details the terms of the bond, including interest rates, maturity, conversion rights, and call/put options. This type of regulatory filing concerning capital structure and financing activities is classified as a Capital/Financing Update.
2021-04-29 Korean
증권발행결과(자율공시)(제12회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, as it reports on the company's fundraising activity through debt instruments.
2021-04-29 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by Solco Biomedical. It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-04-28 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korean stock exchange (KRX) regarding a change in the company's largest shareholder (maximum shareholder). It details the before-and-after ownership stakes, the reason for the change (third-party capital increase), and the identity of the new controlling shareholder. Since this document does not fit into specific categories like 'Director's Dealing' (which is for individual insider trades) or 'Major Shareholding Notification' (which is typically for external investors crossing thresholds), and it is a standard regulatory disclosure of corporate structure change, it is best classified as a Regulatory Filing (RNS).
2021-04-28 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정) by Solco Biomedical Co., Ltd. It details the terms of the bond, including interest rates, maturity, conversion rights, put/call options, and collateral. This type of regulatory filing concerning capital structure and financing activities is classified as a Capital/Financing Update.
2021-04-28 Korean
증권발행결과(자율공시)(제11회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2021-04-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.